Predilife (XPAR:ALPRE) Institutional Ownership : 0.04% (As of May. 27, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Predilife Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Predilife's institutional ownership is 0.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Predilife's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Predilife's Float Percentage Of Total Shares Outstanding is 0.00%.

Predilife Institutional Ownership Historical Data

The historical data trend for Predilife's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predilife Institutional Ownership Chart

Predilife Historical Data

The historical data trend for Predilife can be seen below:

	2020-06-30	2020-07-31	2020-08-31	2020-09-30	2020-10-31	2020-11-30	2020-12-31	2021-01-31	2021-02-28	2021-03-31
Institutional Ownership	0.31	0.31	0.31	0.31	0.31	0.31	0.32	0.32	0.32	0.04

Predilife Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Predilife (XPAR:ALPRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Predilife SA (XPAR:ALPRE) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

114 rue Edouard Vaillant Espace Maurice Tubiana, Villejuif, Paris, FRA, 94800

Website

https://www.predilife.com

Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.

Predilife (XPAR:ALPRE) Headlines

No Headlines